Comparison of Higher-Dose Intradermal Hepatitis B Vaccination to Standard Intramuscular Vaccination of Healthcare Workers | Infection Control & Hospital Epidemiology | Cambridge Core (original) (raw)

References

1.Bryan, J, Iqbal, M, Sjogren, M, et al. Low-dose intradermal recombinant hepatitis B vaccine. ICAAC. Houston, TX; September 1989;133. Abstract 196.Google Scholar

2.Lancaster, D, Elam, S, Kaiser, AB. Immunogenicity of the intradermal route of hepatitis B vaccination with the use of recombinant hepatitis B vaccine. Am J Infect Control 1989;17:126–129.CrossRefGoogle ScholarPubMed

3.Bryan, JP, Sjogren, M, Iqbal, M, Khattak, AR, Nabi, S, Ahmed, A, et al. Comparative trial of low-dose, intradermal, recombinant- and plasma-based hepatitis B vaccines. J Infect Dis 1990;162:789–793.CrossRefGoogle Scholar

4.Heijtink, RA, Breukers, AA, den Hartigh, G, Schepman, RW, Schmitz, I, Schalm, SW, et al. Low-dose intradermal vaccination against hepatitis B in mentally retarded patients. Vaccine 1988;6:59–61.CrossRefGoogle ScholarPubMed

5.McMaster, KR III, Roper, JK, Carter, JB. Intradermal hepatitis B vaccination in a 300-bed primary care hospital: experience with a recombinant vaccine in a four-dose schedule. Am J Infect Control 1993;21:283–288.CrossRefGoogle Scholar

6.Parish, DC, Muecke, HW, Joiner, TA, Pope, WT, Haider, SC. Immunogenicity of low-dose intradermal recombinant DNA hepatitis B vaccine. Southern Medical Journal 1991;84:426–430.CrossRefGoogle ScholarPubMed

7.Wistrom, J, Settergren, B, Gustafsson, A, Juto, P, Norrby, RS. Intradermal versus intramuscular hepatitis B vaccination. JAMA 1990;264:181–182.CrossRefGoogle Scholar

8.Redfield, RR, Innis, BL, Scott, RM, Cannon, HG, Bancroft, WH. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine: a cost strategy. JAMA 1985;254:3203–3206.CrossRefGoogle Scholar

9.Prasetya, E, Linggadjaja, W, Syambali, R, Kusumo, S, Dharmesetyawan, DF, Rahardja, U. Intradermal vaccination against hepatitis B in Immanuel Hospital personnel—a preliminary report. Ann Academic Medicine 1986;15:153–157.Google ScholarPubMed

10.Halsey, NA, Reppert, EJ, Margolis, HS, Francis, DP, Fields, HA. Intradermal hepatitis B vaccination in an abbreviated schedule. Vaccine 1986;4:228–232.CrossRefGoogle Scholar

11.Wahl, M, Hermodsson, S. Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response. Scandinavian Journal of Infectious Diseases 1987;19:617–621.CrossRefGoogle ScholarPubMed

12.Gonzalez, ML, Usandizaga, M, Alomar, P, Salva, F, Martin, F, Erroz, MJ, et al. Intradermal and intramuscular route for vaccination against hepatitis B. Vaccine 1990;8:402–404.CrossRefGoogle ScholarPubMed

13.Bryan, JP, Sjogren, MH, Perine, PL, Legters, LJ. Low-dose intradermal and intramuscular vaccination against hepatitis B. Clin Infect Dis 1991;14:697–707.CrossRefGoogle Scholar

14.Hadler, SC, Francis, DP, Maynard, JE, Thompson, SE, Judson, FN, Echenberg, DF, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315: 209–214.CrossRefGoogle ScholarPubMed

15.Barnes, GP, Hanacik, LJ. Hepatitis B Vaccine: persistence of antibody following immunization. Infect Control Hosp Epidemiol 1988;9:147–150.CrossRefGoogle Scholar

16.McKinney, WP, Horowitz, M, Battiola, R, Russler, S. Duration of response to intramuscular versus low-dose intradermal hepatitis B booster vaccination. ICAAC. Houston, TX; September 1989;17:131. Abstract 181.Google Scholar

17.West, DJ. Clinical experience with hepatitis B vaccine. Am J Infect Control 1989;17:172–180.CrossRefGoogle Scholar

18.Centers for Disease Control. Update on hepatitis B prevention. MMWR 1987;36:353–366.Google Scholar

19.Szmuness, W, Stevens, CE, Harley, EJ. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. N Engl J Med 1982;307:1481–1486.CrossRefGoogle ScholarPubMed

20.Szmuness, W, Stevens, CE, Zang, EA, Harley, EJ, Kellner, A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptovax B): a final report. Hepatology 1981;1:377–385.CrossRefGoogle Scholar

21.Krugman, S, Davidson, M. Hepatitis B vaccine: prospects for duration of immunity. Yale Journal of Biological Medicine 1987;60:333–338.Google ScholarPubMed